Axogen (AXGN) Interest & Investment Income (2010 - 2026)
Axogen's (AXGN) quarterly Interest & Investment Income came in at $768000.0 in Q1 2026, up 182.35% year-on-year from $272000.0 in Q1 2025, and up 118.18% quarter-over-quarter from $352000.0 in Q4 2025.
Axogen (AXGN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Axogen's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $768000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 182.35% year-over-year to $768000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 48.57% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 2.37% from the prior year.
- Interest & Investment Income climbed to $768000.0 in Q1 2026 per AXGN's latest filing, from $352000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $768000.0 in Q1 2026 and bottomed at -$46000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $296000.0 (2024), against an average of $301941.2.
- Biggest YoY gain for Interest & Investment Income was 2953.85% in 2022; the steepest drop was 235.29% in 2022.
- Year by year, Interest & Investment Income stood at $397000.0 in 2022, then declined by 15.37% to $336000.0 in 2023, then retreated by 3.27% to $325000.0 in 2024, then gained by 8.31% to $352000.0 in 2025, then soared by 118.18% to $768000.0 in 2026.
- Per Business Quant, the three latest AXGN Interest & Investment Income figures stand at $768000.0 (Q1 2026), $352000.0 (Q4 2025), and $319000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Axogen | 2.12 Bn | 2.02 Bn | 46.19 Mn | 768,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 768,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Dec 31, 2024 | 325,000.00 |
| Sep 30, 2024 | 296,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 293,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 235,000.00 |
| Mar 31, 2023 | 549,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 29,000.00 |